EU copper intakes up for review

By Shane STARLING

- Last updated on GMT

EU copper intakes up for review
Stakeholders have until August 6 2015 to submit comments to EFSA on draft dietary reference values (DRVs) for copper in the European Union.

Using mean observed intakes in several EU countries, the European Food Safety Authority (EFSA) proposed Adequate Intakes (AIs) ranging from 0.4 mg/day for infants, 1.5 mg/day for pregnant and lactating women, to 1.6 mg/day for adult males and 1.3 mg/day for adult females.

Copper is found in grain, meat, roots, coffee and tea, fish and other seafood and is typical in supplement products like multivitamins.

The mineral has eight approved health claims in the EU under article 13.1 of the nutrition and health claims regulation (NHCR) ranging from immunity benefits, to cell protection, hair and skin pigmentation, connective tissue support, nervous system function to iron transportation.

Copper deficiency can provoke anaemia, neurological defects, changes in hair colour and floppy skin (cutis laxa).

Intake surveys in eight EU member states and other data found typical levels range from 1.47 to 1.67 mg/day in men and 1.20 to 1.44 mg/day in non-pregnant women.

It stated: “The Panel noted that there is, at present, insufficient evidence to set different DRVs according to age in adults, but decided to set different AI values for women and men since intakes are lower for women.”

Other levels included 0.7 mg/day for 1-3 year olds; 1 mg/day for 3-10 year olds; 1.3 mg/day for 10-18 year old boys and 1.1 mg/day for 10-18 year old girls.

EFSA’s Panel on Nutrition, Dietetic Products and Allergies (NDA) draft opinion is here​.

An AI is the value estimated when a Population Reference Intake (PRI) cannot be established because an average requirement cannot be determined. An AI is the average observed daily level of intake by a population group (or groups) of apparently healthy people that is assumed to be adequate. More about the differences between AIs and other measures can be found here​ ​.

Related news

Show more

Related products

show more

Research for Restorative Sleep: Levagen®+

Research for Restorative Sleep: Levagen®+

Content provided by Gencor | 27-Sep-2024 | White Paper

Levagen®+ is Gencor's branded Palmitoylethanolamide (PEA), an endogenous fatty acid amide naturally found in every cell of the body.

Looking to capitalize on market trends quickly?

Looking to capitalize on market trends quickly?

Content provided by Lonza | 25-Sep-2024 | Product Brochure

Lonza’s ready-to-go formulas can help you keep up with the most in-demand health categories, including joint health & mobility, digestive health (probiotics),...

Research for Restorative Sleep: Levagen®+

Research for Restorative Sleep: Levagen®+

Content provided by Gencor | 09-Sep-2024 | White Paper

Levagen®+ is Gencor's branded Palmitoylethanolamide (PEA), an endogenous fatty acid amide naturally found in every cell of the body.

Related suppliers

Follow us

Products

View more

Webinars